Drugs / Temazepam
last change Feb 2019 re-read 8 days ago

Temazepam

Small molecule

Developed for
chronic obstructive pulmonary disease · insomnia · sleep disorder
Investigated by
Hannover Medical School · Rijnstate Hospital

Regulatory milestones approvals, filings & regulatory actions · 4 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansions (2) US (FDA) TEMAZEPAM — 2009-06-12 – 2010-05-21 fda.gov ↗
Label expansion US (FDA) RESTORIL — 1991-10-25 fda.gov ↗
Approved US (FDA) RESTORIL — 1981-02-27 fda.gov ↗

Trials 2

1980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 32 trials
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Phase 3 NCT00245661 Oct 2005 → Aug 2007 chronic obstructive pulmonary disease Rijnstate Hospital Completed No outcome recorded
Comparator or background therapy6 trials
Phase 1 NCT02033707 Background Apr 2014 → Feb 2019 — Johns Hopkins University Completed No outcome recorded
Phase 1 NCT00940550 Comparator Jul → Aug 2009 insomnia University of Surrey Completed No outcome recorded
Phase 4 NCT02153788 Comparator Sep 2009 → Sep 2010 insomnia Duke University Completed No outcome recorded
Phase 4 NCT00465972 Comparator Mar 2007 → Aug 2010 HIV infectious disease, insomnia Duke University Completed No outcome recorded
— NCT02288923 Comparator Mar 2015 → Jul 2018 osteoarthritis, knee Royal Devon and Exeter NHS Foundation Trust Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as temazepam “Sedatives/anxiolytics: alprazolam, diazepam, lorazepam, secobarbital, temazepam, triazolam, zolpidem” NCT02033707 ↗
7

“Patients may be given anxiolysis using temazepam 10-20mg or diazepam 2-5mg by mouth if required.” NCT02288923 ↗

NCT00245661 ↗

NCT01519544 ↗

NCT00940550 ↗

NCT00465972 ↗

NCT02374567 ↗

NCT02153788 ↗

Known as (rs)-temazepam ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Known as Kentepam ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Known as Normison ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Known as NSC-246303 ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Known as Restoril ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Known as Temaz ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Known as Temazepam civ ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Known as WY-3917 ChEMBL registry synonym — accepted as the source's own label CHEMBL967 ↗
Modality Small molecule — CHEMBL967 ↗
Route Oral “Temazepam capsule 15 mg po nightly x duration of study” NCT00465972 ↗